New drug candidates for depression - a nationwide population-based study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New drug candidates for depression - a nationwide population-based study
Authors
Keywords
-
Journal
ACTA PSYCHIATRICA SCANDINAVICA
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-09-05
DOI
10.1111/acps.12957
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials
- (2018) Alexander T. Chen et al. JOURNAL OF AFFECTIVE DISORDERS
- The promise and challenges of drug repurposing in psychiatry
- (2018) Maurizio Fava World Psychiatry
- Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial
- (2018) Jonathan B. Savitz et al. Translational Psychiatry
- Psychological issues and cognitive impairment in adults with familial hypercholesterolemia
- (2017) Mariana Suárez Bagnasco FAMILY PRACTICE
- Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years
- (2017) Nicola Veronese et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- Multimorbidity and depression: A systematic review and meta-analysis
- (2017) Jennifer R. Read et al. JOURNAL OF AFFECTIVE DISORDERS
- Chronic pain, depression and cardiovascular disease linked through a shared genetic predisposition: Analysis of a family-based cohort and twin study
- (2017) Oliver van Hecke et al. PLoS One
- Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population
- (2016) Marie Kim Wium-Andersen et al. BRITISH JOURNAL OF PSYCHIATRY
- Low-dose aspirin or other nonsteroidal anti-inflammatory drug use and prostate cancer risk: a nationwide study
- (2016) Charlotte Skriver et al. CANCER CAUSES & CONTROL
- Angiotensin Converting Enzyme Inhibitors and Risk of Mood Disorders
- (2016) Lana J. Williams et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Three Paths to Drug Discovery in Psychiatry
- (2015) Michael Berk et al. AMERICAN JOURNAL OF PSYCHIATRY
- Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients
- (2015) Payam Mohammadinejad et al. ANNALS OF PHARMACOTHERAPY
- A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control
- (2015) Adrienne O’Neil et al. BMC Psychiatry
- Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders
- (2015) Mark J. Millan et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Aspirin and statin use and the subsequent development of depression in men and women: Results from a longitudinal population-based study
- (2015) Jennifer Glaus et al. JOURNAL OF AFFECTIVE DISORDERS
- Prevalence of Depression in Patients With Hypertension
- (2015) Zhanzhan Li et al. MEDICINE
- Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease
- (2015) Lars Vedel Kessing et al. JAMA Psychiatry
- The use of statins for the treatment of depression in patients with acute coronary syndrome
- (2015) S W Kim et al. Translational Psychiatry
- Identification of novel therapeutics for complex diseases from genome-wide association data
- (2014) Mani P Grover et al. BMC Medical Genomics
- Statin use and risk of depression: a Swedish national cohort study
- (2014) Cassie Redlich et al. BMC Psychiatry
- In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder
- (2014) Leila Jahangard et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
- (2014) Eva Haastrup et al. PLoS One
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness
- (2013) Michael Berk et al. BMC Medicine
- CRP, IL-6 and depression: A systematic review and meta-analysis of longitudinal studies
- (2013) Vyara Valkanova et al. JOURNAL OF AFFECTIVE DISORDERS
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- (2013) Harvey A Whiteford et al. LANCET
- The impact of statins on psychological wellbeing: a systematic review and meta-analysis
- (2012) Adrienne O'Neil et al. BMC Medicine
- Something's got to give: psychiatric disease on the rise and novel drug development on the decline
- (2012) Daniel J. Chandler DRUG DISCOVERY TODAY
- Pain and the relationship with mood and anxiety disorders and psychological symptoms
- (2012) Lana J. Williams et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- The economic cost of brain disorders in Europe
- (2011) J. Olesen et al. EUROPEAN JOURNAL OF NEUROLOGY
- ASPIRIN USE, DEPRESSION, AND COGNITIVE IMPAIRMENT IN LATER LIFE: THE HEALTH IN MEN STUDY
- (2010) Osvaldo P. Almeida et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and monoamine metabolite concentrations in cerebrospinal fluid
- (2010) Kristina Annerbrink et al. PSYCHIATRY RESEARCH
- Clinical Implications of the Cytokine Hypothesis of Depression: The Association between Use of Statins and Aspirin and the Risk of Major Depression
- (2010) Julie A. Pasco et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- An Association Between Selective Serotonin Reuptake Inhibitor Use and Serious Upper Gastrointestinal Bleeding
- (2009) Michael Dall et al. Clinical Gastroenterology and Hepatology
- Lithium Treatment and Risk of Dementia
- (2008) Lars Vedel Kessing et al. ARCHIVES OF GENERAL PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started